about
Efficient assembly of de novo human artificial chromosomes from large genomic loci.Visualization of targeted transduction by engineered lentiviral vectorsCurrent and Future Gene Therapy for Malignant GliomasRapid creation of BAC-based human artificial chromosome vectors by transposition with synthetic alpha-satellite arraysLipopolyplex for Therapeutic Gene Delivery and Its Application for the Treatment of Parkinson's DiseaseGene delivery strategies to promote spinal cord repairIon channel remodeling in vascular smooth muscle during hypertension: Implications for novel therapeutic approachesTargeting cancer gene therapy with magnetic nanoparticlesBone repair cells for craniofacial regeneration.Nanomaterials and autophagy: new insights in cancer treatmentBiology-inspired microphysiological system approaches to solve the prediction dilemma of substance testingPatient-Specific Therapy via Cell-Reprogramming Technology: a Curative Potential for Patients with DiabetesProtein-anchoring strategy for delivering acetylcholinesterase to the neuromuscular junction.Crystalline magnetic carbon nanoparticle assisted photothermal delivery into cells using CW near-infrared laser beam.Diverse activities of viral cis-acting RNA regulatory elements revealed using multicolor, long-term, single-cell imagingTertiary-amine functionalized polyplexes enhanced cellular uptake and prolonged gene expression.The road ahead: working towards effective clinical translation of myocardial gene therapies.Improvement in nuclear entry and transgene expression of baculoviruses by disintegration of microtubules in human hepatocytes.Silica nanoparticle supported lipid bilayers for gene delivery.Evaluation of biolistic gene transfer methods in vivo using non-invasive bioluminescent imaging techniquesDelivery of the Cre recombinase by a self-deleting lentiviral vector: efficient gene targeting in vivo.Gene therapy: design and prospects for craniofacial regeneration.Restoration of spermatogenesis by lentiviral gene transfer: offspring from infertile mice.RNA 3' readthrough of oncoretrovirus and lentivirus: implications for vector safety and efficacy.Generation of a selectively cytotoxic fusion protein against p53 mutated cancersA constitutively active Gαi3 protein corrects the abnormal retinal pigment epithelium phenotype of Oa1-/- miceGlioma cell growth inhibition following photochemical internalization enhanced non-viral PTEN gene transfection.Gene therapy strategies for the treatment of chronic viral hepatitis.Current gene therapy for stomach carcinoma.Therapeutic ultrasound: its application in drug delivery.Non viral vectors in gene therapy- an overview.Targeting lentiviral vectors to specific cell types in vivo.Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system.Current status of gene therapy for inherited lung diseasesCeliac disease: a model autoimmune disease with gene therapy applications.Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy.Perinatal gene transfer to the liver.Gene delivery in salivary glands: from the bench to the clinicHuman serum albumin-based nanoparticle-mediated in vitro gene deliveryNovel viral vector systems for gene therapy.
P2860
Q21256662-D198C488-D6A9-4C7D-B271-27BB8C5309BAQ24646930-E8E047B0-0227-40B3-A221-BAC5DE5D68A2Q24792748-89F851D4-9FC7-45AB-93D5-820D8BACB1A2Q24801853-33381A53-08A7-4CE5-9625-58FF813D743AQ26752578-C186D599-801E-4278-A37A-59027AFE3B2BQ26825131-C6117A72-A7D8-4578-A8DB-9B79389CB8ABQ26996048-8786582C-C5BF-4D49-930C-66FB6F114E77Q26996505-440C748B-D07D-4962-8394-0A0596F53625Q27691449-11BFBED4-9B30-4D70-8BBB-7A61B009DB2EQ28386642-8696EA3F-2666-4D53-AC39-515C2B277CEDQ30358385-48D0183B-AF4E-4B60-8633-DE0F90F2F945Q30394255-B36BF464-8261-46D2-9C33-C1AF0061C9AFQ30519561-EC7AE855-6721-4173-8F69-5FC95DA191DFQ30579120-DD8931DA-8D91-48B8-A088-5D321744B2C7Q30841153-77F0AB46-4A93-43F1-9CA9-361965B6EAA3Q33610596-3936C1DD-8E32-4961-8B50-8843A82E7AA0Q33705144-B47957BE-FFD4-459F-B228-326FE09760FBQ33834978-9A5CC2B3-A5EA-497B-9B9D-A7351805B4E5Q33839296-760AF720-81E3-421D-AEF0-CCEEF0DA7075Q33920307-C4D25632-905C-43B7-B250-25C98D440F48Q33944613-D01F8D9C-1B98-4A84-8987-4ADA2A154F06Q34007347-6E8915BA-9D91-453A-A7F0-AEE79033EF75Q34064323-5AD2E4DD-60E3-4295-B064-ACE2C7491F19Q34342598-21FEB171-CE30-4C2D-898D-04E93701259FQ34365725-4194C381-F8B2-44E9-A6C8-EAF433000D30Q34375713-7E60D322-CB9A-4693-ACA5-A445DDC68C6CQ34423421-4C5A6A73-D4F9-4162-88E6-DF9D2B860D1CQ34451890-03A4AD74-07C9-4ABD-867C-FC782F4BEFD8Q34512167-67441ABA-98AD-4143-BF90-E731A976CD5EQ34540070-8E094FA6-987D-4A97-BB46-3CD086E46577Q34668309-CF1DE287-B58C-4EC3-B059-F2F77A01DACFQ34830842-2CB31445-19AF-4F04-A2E3-9C13B54E2CF7Q35007531-584D671A-CDCA-415B-8A2F-A759584D09FAQ35043830-5E24AFD1-33B4-4B32-B422-2B7A0377082AQ35122155-F38727F5-6853-40BF-B0B3-17F7B4A6132DQ35131227-A1CF8551-5025-41B3-8696-521FC6895219Q35238390-593D9BB8-5FEB-46EB-B30F-60C055C48ED9Q35255990-03CB7112-6FEB-46F4-95F3-2771DB217E75Q35258046-1D91F86D-FC56-4288-B2B4-0671B22BDC98Q35260938-6CFFFCC2-2384-4AEA-97F1-F0C0FAE56FAB
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Gene therapy: trials and tribulations.
@ast
Gene therapy: trials and tribulations.
@en
Gene therapy: trials and tribulations.
@nl
type
label
Gene therapy: trials and tribulations.
@ast
Gene therapy: trials and tribulations.
@en
Gene therapy: trials and tribulations.
@nl
prefLabel
Gene therapy: trials and tribulations.
@ast
Gene therapy: trials and tribulations.
@en
Gene therapy: trials and tribulations.
@nl
P356
P1476
Gene therapy: trials and tribulations.
@en
P2093
P2888
P356
10.1038/35038533
P577
2000-11-01T00:00:00Z
P6179
1012109533